| Effects of PHA-665752 and cetuximab combination treatment on in vitro and murine xenograft growth of human colorectal cancer cells with KRAS or BRAF mutations. | |
| Jia YT; Yang DH; Zhao Z; Bi XH; Han WH; Feng B; Zhi J; Gu B; Duan Z; Wu JH | |
| 刊名 | Curr Cancer Drug Targets
 |
| 2017 | |
| 关键词 | BRAF RAS c-Met cetuximab colorectal cancer |
| ISSN号 | 1568-0096 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/2003860 |
| 专题 | 河北省人民医院 |
| 作者单位 | 1.The Forth Hospital of Hebei Medical University - second Department of Surgery Shijiazhuang. China. 2.The Forth Hospital of Hebei Medical University - Experimental Animal Center Shijiazhuang. China. 3.Hebei General Hospital - department of Oncology Shijiazhuang. China. 4.The Forth Hospital of Hebei Medical University - second Department of Surgery Shijiazhuang, China The Second Affiliated Hospital of Xingtai Medical College - department of Emergency Medicine Xingtai. China. 5.The Forth Hospital of Hebei Medical University - department of Pharmacy Shijiazhuang. China. |
| 推荐引用方式 GB/T 7714 | Jia YT,Yang DH,Zhao Z,et al. Effects of PHA-665752 and cetuximab combination treatment on in vitro and murine xenograft growth of human colorectal cancer cells with KRAS or BRAF mutations.[J]. Curr Cancer Drug Targets,2017. |
| APA | Jia YT.,Yang DH.,Zhao Z.,Bi XH.,Han WH.,...&Li ZX..(2017).Effects of PHA-665752 and cetuximab combination treatment on in vitro and murine xenograft growth of human colorectal cancer cells with KRAS or BRAF mutations..Curr Cancer Drug Targets. |
| MLA | Jia YT,et al."Effects of PHA-665752 and cetuximab combination treatment on in vitro and murine xenograft growth of human colorectal cancer cells with KRAS or BRAF mutations.".Curr Cancer Drug Targets (2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论